Dramatic shifts over the past nine months indicate that a market rebalancing is underway, with investments and valuations lowering from 2021’s boom. However, the healthcare industry is more resilient during periods of downturn and remains ripe for innovation, Silicon Valley Bank reports.
Inflation, global geopolitical factors and interest rate hikes all created a tumultuous public market and shut healthtech’s IPO window. However, private VC-backed M&A this year are up 16% versus the first three quarters of 2021. Read more.
